Efect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1154-1158

  Zimmer, Guido ^a   Balakirev, Maxim ^a,c   Zwicker, Klaus ^a   Hofmann, Michael ^a   Woodcock, Barry G ^a   Pergande, Gabriela ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ASTA MEDICA AG   (Germany)

^c INSTITUTE OF CHEMICAL KINETICS AND COMBUSTION   (Russian Federation)

Author keywords

ATP synthesis; Ca2+ transport; Membrane permeability transition; Membrane potential; Mitochondria (rat heart); Swelling contraction cycle

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANALGESIC AGENT; CALCIUM ION; FLUPIRTINE; PROTEIN; AMINOPYRIDINE DERIVATIVE; CALCIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DAMAGE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MITOCHONDRION; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE POTENTIAL; DRUG EFFECT; METABOLISM; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; AMINOPYRIDINES; ANALGESICS; ANIMALS; CALCIUM; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA, HEART; RATS; RATS, WISTAR;

EID: 0031596641     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701736     Document Type: Article

References (23)

1. AKERMAN, K.E.O. & WIKSTRÖM, M.K.E. (1976). Safranine as a probe of the mitochondrial membrane potential. FEBS Lett., 63, 191-197.
2. BEREITER-HAHN, J. (1976). Dimethylaminostyrylmethylpyridiniumiodine (DASPMI) as a fluorescent probe for mitochondria in situ. Biochim. Biophys. Acta, 423, 1-14.
3. BERNARDI, P., BROEKEMEIER, K.M. & PFEIFFER, D.R. (1994). Recent progress in regulation of the mitochondrial permeability transtition pore: a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr., 26, 509-517.
4. BERNARDI, P. & PETRONILLI, V. (1996). The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J. Bioenerg. Biomembr., 28, 131-138.
5. HLAVICA, P. & NIEBCH, G. (1985). Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin beim Menschen. Arzneim.-Forsch./Drug Res., 35, 67-74.
6. MELA, L. & SEITZ, S. (1979). Isolation of mitochondria with emphasis on heart mitochondria from small amounts of tissue. Meth. Enzymol., 55, 39-46.
7. MILLOT, J.M., PINGRET, L., ANGIBOUST, J.F., BONHOMME, A., PINON, J.-M. & MANFAIT, M. (1995). Quantitative determination of free calcium in subcellular compartments, as probed by INDO-1 and confocal microspectrofluorometry. Cell Calcium., 17, 334-366.
8. MOORE, R.A., BULLINGHAM, R.E.S., SIMPSON, S., O'SULLIVAN, G., EVANS, P.J.D., MCQUAY, H.J. & LLOYD, J.W. (1983). Comparison of flupirtine malate and dihydrocodeine in patients following surgery. Br. J. Anaesth., 55, 429-432.
9. OSBORNE, N.N., PERGANDE, G., BLOCK, F. & SCHWARZ, M. (1994). Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rabbit retina. Brain Res., 667, 291-294.
10. OSBORNE, N.N., SCHWARZ, M. & PERGANDE, G. (1996). Protection of rabbit retina from ischemic injury by flupirtine. Invest. Ophthalmol. Visual Sci., 37, 274-280.
11. PACKER, L. (1960). Metabolic and structural states of mitochondria. I. Regulation by adenosine diphosphate. J. Biol. Chem., 235, 242-249.
12. PALMER, J.W., TANDLER, B. & HOPPEL, C.W. (1977). Biochemical properties of subsarcoluminal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem., 252, 8731-8739.
13. PEROVIC, S., SCHLEGER, C., PERGANDE, G., ISKRIC, S., USHIJIMA, H., RYTIK, P. & MÜLLER, W.E.G. (1994). The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp 120 of HIV-1. Eur. J. Pharmacol., 288, 27-33.
14. 2+ concentration. Eur. J. Pharmacol., 294, 469-473.
15. 2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur. J. Pharmacol., 276, 247-255.
16. THÜRICH, T., BEREITER-HAHN, J., SCHNEIDER, M. & ZIMMER, G. (1997). Cardioprotective effects of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress. Arzneim.-Forsch./Drug Res., (in press).
17. ZAMZAMI, N., SUSIN, S.A., MARCHETTI, P., HIRSCH, T., GOMEZ-MONTERREY, I., CASTEDO, M. & KROEMER, G. (1996). Mitochondrial control of nuclear apoptosis. J. Exp. Med., 183, 1533-1544.
18. ZEMAN, K., ENGELHARD, H. & SACKMANN, E. (1990). Bending undulations and elasticity of the erythrocyte membrane: Effects of cell shape and membrane organization. Eur. Biophys. J., 18, 203-219.
19. ZIMMER, G. (1970). Oligomycin and ADP sensitivity of in vitro alkylation of-SH groups in rat liver mitochondria. FEBS Lett., 9, 274-276.
20. ZIMMER, G. & FREISLEBEN, H.-J. (1988). Membrane fluidity determinations from viscosimetry. In Advances in Membrane Fluidity. Methods for Studying Membrane Fluidity. Vol.1. ed. Aloia, R.C., Curtain, C.C., & Gordon, L.M. 297-318. New York: Alan Liss.
21. ZIMMER, G., FREISLEBEN, H.-J. & FUCHS, J. (1990). Influence of pH on sulfhydryl groups and fluidity of the mitochondrial membrane. Arch. Biochem. Biophys., 282, 309-317.
22. ZIMMER, G., MAINKA, L. & ULRICH, H. (1995a). ATP synthesis and ATPase activities in heart mitoplasts under influence of R- and S-enantiomers of lipoic acid. Meth. Enzymol., 251, 332-340.
23. ZIMMER, G., BEIKLER, T.-K., SCHNEIDER, M., IBEL, J., TRITSCHLER, H. & ULRICH, H. (1995b). Dose/response curves of lipoic acid R- and S-forms in the working rat heart during reoxygenation: superiority of the R-enantiomer in enhancement of aortic flow. J. Mol. Cell Cardiol., 27, 1895-1903.